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In today’s world, obesity is a prevalent disease in both 
developed and developing countries (1). It is a well-documented
fact that obese people suffer from increased mortality risk 
due to cardiovascular complications (2,3,4). The assumption that
the sympathoadrenal system plays a major role in the 
pathophysiology of obesity through regulation of energy 
expenditure is widely accepted (5). Chronic sympathetic 
overstimulation and increased catecholamine levels have been
incriminated in obesity (6,7). Some authors have suggested that
obese individuals demonstrate altered reactions to stressors (8).
Equally unresolved is the question of whether the aberrations in
the sympathetic system contribute to obesity or they are rather
a consequence of it (9). 
While obesity in childhood is also known to be highly 
associated with multiple co-morbidities such as hypertension,
dyslipidemia, reduced insulin sensitivity and alterations in large
and small blood vessels (10), the number of studies that analyze
the autonomic functions in obese pediatric populations is still
limited.
Heart rate variability (HRV), defined as degree of fluctuation
of the beat-to-beat differences in cardiac rhythm, is known to 
be a reliable, noninvasive marker of autonomic nervous system
activity (11,12). The loss of this beat-to-beat variability is 
indicative of various diseases (13,14,15,16,17,18). Detection 
of such changes, especially for the evaluation of autonomic
nervous system functions, may be used as a marker of 
underlying pathology.
In this case-control study, we aimed to investigate the 
cardiac autonomic function by using time-domain and 
frequency-domain parameters of HRV in children with obesity.
ABSTRACT
Objective: The autonomic nervous system is assumed to have a role in the
pathophysiology of obesity. In this study, we evaluated the autonomic system
by measuring heart rate variability (HRV) in obese children.  
Methods: Thirty-two obese and 30 healthy children (mean ages: 11.6±2.0
years and 11.0±2.9 years, respectively) were enrolled in the study. Obesity
was defined as a body mass index higher than 97th percentile for age- and
gender-specific reference values. All participants were free of any disease and
none of them was receiving any medication. Twenty-four-hour ambulatory
electrocardiographic recordings were obtained and the time-domain 
and frequency-domain indices of HRV were analyzed. The study group was
evaluated with respect to insulin resistance by HOMA-IR values. 
Results: A significant decrease in calculated HRV variables was
observed in obese children as compared to controls. The HRV alteration
was found in both time-domain and frequency-domain parameters. The
subgroup analysis of the study group revealed a significant decrease in all
investigated HRV parameters in the insulin-resistant obese children 
compared to the non-insulin-resistant obese ones.
Conclusions: Our results indicate that HRV is decreased in obese children,
which implies parasympathetic withdrawal and sympathetic predominance. A
marked decrease in HRV was observed in insulin-resistant obese children
compared to their non-insulin-resistant counterparts. We propose that 
autonomic imbalance pertaining especially to insulin resistance may be
involved in the pathogenesis of obesity in pediatric patients    
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The study group consisted of 32 consecutive obese 
children (20 male, 12 female) with a mean age of 11.6±2.0
years and the control group included 30 age- and 
gender-matched healthy children (19 male, 11 female; mean
age: 11.0±2.9 years). Control subjects were chosen from
among those who presented to our outpatient clinic for routine
check-up. To exclude the presence of any concomitant disease,
a detailed medical history was obtained and a physical 
examination (including evaluation for syndromes and endocrine
diseases) was performed. Complete blood count and blood
chemistry, consisting of fasting insulin, thyroid function tests
and serum cortisol, were evaluated to rule out any underlying
pathology.  Children with obesity-related entities such as 
syndromic (Prader-Willi syndrome, Laurence-Moon-Biedl 
syndrome, etc.) and endocrine (Cushing’s syndrome, 
hypothyroidism, etc.)  diseases were excluded from the study.
The study protocol was reviewed and approved by the local
ethics committee.
Weight and height measurements were done with the 
children wearing light clothes and no shoes. Standing height
(cm) was measured to the nearest 0.1 cm with a Harpenden
fixed stadiometer and body weight (kg) on a SECA balance
scale to the nearest 0.1 kg. Body mass index (BMI) was 
calculated as weight (kg) divided by the square of the height
(m). Obesity was defined as a BMI value higher than the 97th
percentile value for age and gender, using the definition and 
reference values proposed by the International Obesity 
Task Force in Childhood (19,20). The degree of obesity was
quantified using Cole’s least mean square method, which 
normalizes BMI skewed distribution and expresses BMI in
standard deviation scores (SDS). This measure gives age- and
sex-specific estimates for median of distribution, coefficient 
of variation and degree of skewness by a maximum-likelihood
fitting technique (20). Control subjects were chosen from
among those having a BMI below 85th percentile for age 
and gender. None of the participants was receiving any 
medical treatment or had a history or evidence of metabolic,
cardiovascular, respiratory or hepatic disease. Pubertal 
development was assessed according to Tanner criteria (21)
and the children were evaluated as prepubertal and pubertal.
Fasting plasma glucose, serum triglyceride (TG), total 
cholesterol (TC) and high-density lipoprotein-cholesterol 
(HDL-C) concentrations were measured enzymatically using an
autoanalyzer (Olympus 2700, Olympus Medical Systems Corp.,
Tokyo, Japan). The low-density lipoprotein-cholesterol (LDL-C)
level was calculated using the Friedewald equation. Plasma
insulin was measured by the electrochemiluminescence
immunoassay method using an automated immunoassay 
analyzer (E170, Roche, Hitachi, Osaka, Japan). The children and
their parents had been carefully instructed that a fasting period
of at least 12-14 hours should be provided. Cut-off points above
the 95th percentile of healthy children were used to 
determine dyslipidemia and impaired fasting glucose according
to international recommendations (22,23).
In the obese group, insulin sensitivity was determined by
using the homeostasis model assessment for insulin resistance
(HOMA-IR). HOMA-IR was calculated using the equation:
HOMA-IR=fasting insulin (μU/mL) x fasting glucose
(mg/dL)/405. Obese children were subdivided according to their
HOMA-IR values as insulin-resistant and non-insulin-resistant.
Insulin resistance was defined as HOMA-IR values above 2.67
and 2.22 for prepubertal boys and girls, respectively, and above
5.22 and 3.82 for pubertal boys and girls in the same order (24).
Heart Rate Variability  
Twenty-four-hour ambulatory electrocardiographic 
recordings were obtained from each subject with Rozinn RZ
152 digital Holter recorder (Rozinn Electronics, Inc., Glendale,
NY, USA), with a sampling frequency of 1024 Hz. All cases
were strictly advised to maintain the normal course of their daily
life. Their compliance was confirmed again while removing the
device from the cases. The HRV was determined by the 
software of the same device.
The time-domain HRV measures employed in our study
were as follows:  standard deviation values of all normal sinus
R-R intervals over 24 hours (SDNN); standard deviation values
of all averaged normal sinus R-R intervals for each 5-minute
segment in the 24-hour recordings (SDANN); root mean
squares of successive differences between normal sinus R-R
intervals (RMSSD); ratios of number of all R-R intervals to height
of the histogram created by charting all R-R intervals (HRV 
triangular index); numbers of R-R intervals exceeding 50 ms
(SNN50 count);  percentage of difference between adjacent
normal R-R intervals that are greater than 50 ms computed over
the entire 24-hour ECG recording (PNN50). Among 
them, RMSSD, SNN50, and PNN50 primarily reflect 
parasympathetically mediated changes in heart rate (25). Other
time-domain variables reflect a mixture of parasympathetic,
sympathetic, and other physiologic influences. 
We used power spectral analysis of heart rate with 
parameters of low frequency (LF: 0.04-0.15 Hz) which are 
related to baroreceptor control and are dually mediated by vagal
and sympathetic systems, as well as those of high frequency
(HF: 0.15 – 0.5 Hz) which reflect respiratory sinus arrhythmia
and thus, cardiac vagal activity (26,27). Also, the most indicative
parameter of LF/HF was used for assessing the autonomic 
balance. 
Statistical Analysis
We used SPSS for Windows, Version 15 software (SPSS
Inc., Chicago, IL., USA) in the analyses. The Shapiro-Wilk test
was used to test for normality of variables. The decision to 
perform parametric testing was based on the result of this test
for continuous variables. Comparisons between the groups
were carried out with two-tailed Student’s t-test for normally
distributed continuous variables, Mann-Whitney U test for 
continuous variables without normal distribution, and chi-square
test for dichotomous variables. P values below 0.05 were 
considered as significant.
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In the study group, 8 (25%) children had 
hypertriglyceridemia, 4 (13%) hypercholesterolemia, 2 (6%)
increased LDL-C levels, 6 (19%) decreased serum HDL-C 
levels, and 21 (66%) showed impaired fasting glucose. None of
the lean subjects had impaired fasting glucose.
There was no significant difference with regard to age 
and gender between the study group and the control 
group (p=0.857 and p=0.578, respectively). Demographic,
anthropometric, and biochemical characteristics of the 
participants are given in Table 1. As seen in the Table, the
obese group had significantly higher insulin, TG, VLDL-C and
lower HDL-C levels than the control group.
HRV indices for both time-domain and frequency-domain
and their statistical comparison between the groups are 
illustrated in Table 2. The study and control groups were found
to be statistically different in all parameters, except SDNN.
While SDANN, RMSSD, NN50 index, NN50 count, PNN50,
HRV-triangular index, LF and LF/HF were significantly lower in
the study group than in the control group, the HF was found to
be significantly higher in the study group than in the control
group. 
When we categorized the study group according to their
HOMA-IR values, 21 children (14 male, 7 female) were found
to have insulin resistance, while 11 (6 male, 5 female) did not.
The comparisons of HRV values between insulin-resistant and
non-resistant subgroups are shown in Table 3. 
Discussion 
The results of our study show that both time-domain and
frequency-domain parameters of HRV were decreased 
in obese children - a finding, reflecting parasympathetic 
withdrawal and sympathetic predominance. Also, the subgroup
analysis of the study group demonstrated a marked 
parasympathetic withdrawal and resulting sympathetic 
predominance in the insulin-resistant group as compared to the
group with no resistance to insulin. 
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Table 1. Demographic, clinical and biochemical values in the obese and control groups  
Parameter Obese children Control group p value
Age (years) 10.9±2.6 (8-14) 11±2.99 (8-15) 0.857*
Gender
Male 20 19 0.578†
Female 12 11
BMI SDS  2.1±0.2 0.046±0.83 <0.001*
Serum fasting glucose (mg/dL) 91.6±9.5 (73-106) 89.1±8.9 (70-100) 0.123*
Fasting insulin (μU/mL) 14.1±6.7 (5-31) 8.4±3.7 (4-12) <0.001‡
Total cholesterol (mg/dL) 175.9±36.8 166.2±25.2 0.177*
(126-253) (114-200)
Triglyceride (mg/dL) 129.7±70.8 81±40.9 <0.001‡
(51-282) (49-180)
HDL-cholesterol (mg/dL) 46.8±13.1 (34-68) 55.4±13 (42-71) 0.004*
LDL-cholesterol (mg/dL) 102.5±29.6 (60-159) 93.3±27.9 (54-140) 0.190*
VLDL-cholesterol (mg/dL) 24.7±10.2 (12-51) 15.4±7.4 (9-32) <0.001‡
AST (IU) 24.6±7.1 (12-41) 21.4±7.5 (14-33) 0.065*
ALT (IU) 28.3±11.3 (13-67) 24.1±10.3 (10-45) 0.091*
GGT (IU) 28.2±15.8 (16-49) 25.9±14.8 (12-40) 0.215‡
BMI SDS: body mass index standard deviation score; HDL: high-density lipoprotein; LDL: low-density lipoprotein; VLDL: very low-density lipoprotein; AST: aspartate aminotransferase;
ALT: alanin aminotransferase; GGT: gamma glutamyl transferase. 
*: two-tailed Student’s t-test; †: chi-square test; ‡: Mann-Whitney U test. 
Values represent mean ± standard deviation, and minimum and maximum in parenthesesUsing power spectral analysis, Piccirillo et al (8) reported
that obesity was associated with decreased sympathetic
responsiveness. Obese subjects showed a higher presynaptic
activation level as indicated by plasma norepinephrine levels. At
the same time, postsynaptic sympathetic responsiveness 
was diminished in these subjects. The decreased sympathetic
reactivity to stress was thought to be a contributing factor to
the higher mortality rates. A low sympathetic activity was also
reported by Peterson et al (28).
Rossi et al (6) reported a lower parasympathetic function 
in obese subjects, but found no differences in sympathetic
functions between normal and obese individuals. The former
finding was suggestive of a causal role of parasympathetic tone
in sudden death. A decreased parasympathetic activity has also
been reported by Arone et al (29). However, in contrast 
to other studies, these authors found also an increase in the
sympathetic control. Zahorska-Markiewicz et al (30) observed
overreactivity of the sympathetic nervous system, as opposed
to a depression in parasympathetic activity analogous to that
reported by Piccirillo et al (8). A study by Arone et al (29)
showed an increase in parasympathetic activity with 
weight loss and an inverse behavior of sympathetic drive in
moderately overweight subjects, but these results were based
on short-term differences in a population with rather fast weight
changes. In a study on weight gain, Hirsch et al (31) described
an inverse relationship between amount of weight gain and 
lower parasympathetic drive. In obese women, Gao et al (32)
reported higher sympathetic and parasympathetic activity,
especially when there was a combination of upper body 
obesity and visceral obesity. The limited studies conducted in
obese children indicate parasympathetic withdrawal and 
sympathetic predominance with metabolic changes such as
impaired blood lipid profile (33,34,35). 
The results of our study were in line with the 
above-mentioned reports. Our findings revealed 
reduced parasympathetic activity resulting in sympathetic 
predominance. However, in evaluating the autonomic nervous
system, we used only time-domain and frequency-domain
parameters of HRV; therefore, we cannot report any 
conclusions pertaining to the mechanism of this cardiac 
autonomic imbalance. This point should be evaluated by future
large-scale prospective studies using arterial blood pressure
variability and skin tests. However, an important finding of our
study is that insulin-resistant obese children have marked 
sympathetic predominance compared to their non-insulin-
resistant counterparts. Whether insulin resistance causes the
autonomic imbalance or not is not clear. Theories about this
point generally focus on the question of whether autonomic
imbalance is the key factor leading to insulin resistance, 
hypertension and metabolic syndrome or not (36). 
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Table 2. Time-domain and frequency-domain parameters of the obese
and control children 
Parameter Obese children Control group p value
SDNN (ms) 137.8±35.1 142±29 0.096*
SDANN (ms) 101.8±25.1 122±22 <0.001*
RMSSD (ms) 73.2±37.4 89±45 <0.001‡
NN50 index 77.7±24.8 83±29 0.021‡
NN50-count 24472±13173 33276±11293 <0.001‡
PNN50 (%) 26.8±16.4 34±13 0.009‡
HRV triangular index 39.8±11 48±12 <0.001*
LF (n.u.) 2.6±0.9 2.2±1 0.014‡
HF (n.u.) 1.9±1.5 2.5±2.1 0.003‡
LF/HF 1.6±0.7 1.12±0.56 0.007‡
NN50 count: number of R-R intervals exceeding 50 ms; RMSSD: root mean square of
successive differences between normal sinus R-R intervals; PNN50: the percentage
of difference between adjacent normal R-R intervals that are greater than 50 ms 
computed over the entire 24-hour ECG recording; HRV triangular index: the ratio of
number of all R-R intervals to the height of histogram created by the charting all the
RR intervals; SDANN: the standard deviation of all averaged normal sinus R-R 
intervals for each 5-minute segment in the 24-hour recordings; SDNN: the standard
deviation of all normal sinus R-R intervals over 24 hours; LF: low frequency power; 
HF: high frequency power; n.u.: normalized unit
*: two-tailed Student’s t test; ‡: Mann-Whitney U test
Table 3. Time-domain and frequency-domain parameters and their 
comparison between insulin resistant (IR) and non-insulin resistant 
(Non IR)  groups
Parameter IR group Non IR group p value
SDNN (ms) 130.2±32.6 150.1±36.9 <0.001*
SDANN (ms) 96.4±22.3 110±27 <0.001*
RMSSD (ms) 70.6±26.4 78±44 <0.001‡
NN50 index 75.7±24.8 82±29 <0.001‡
NN50-count 21680±10173 29802±12293 <0.001‡
PNN50 (%) 24.1±13.2 31.9±15.6 0.009‡
HRV triangular index 36.4±10 46.3±13 <0.001*
LF (n.u.) 2.7±0.9 2.4±1 0.014‡
HF (n.u.) 1.8±1.5 2.1±2.1 0.003‡
LF/HF 1.5±0.7 1.14±0.56 0.007‡
NN50 count: number of R-R intervals exceeding 50 ms; RMSSD: root mean square of
successive differences between normal sinus R-R intervals; PNN50: the percentage
of difference between adjacent normal R-R intervals that are greater than 50 ms 
computed over the entire 24-hour ECG recording; HRV triangular index: the ratio of
number of all R-R intervals to the height of histogram created by the charting all the
RR intervals; SDANN: the standard deviation of all averaged normal sinus R-R 
intervals for each 5-minute segment in the 24-hour recordings; SDNN: the standard
deviation of all normal sinus R-R intervals over 24 hours; LF: low frequency power; HF:
high frequency power; n.u: normalized unit; *: two tailed Student’s t test; 
‡: Mann-Whitney U testIn conclusion, we found sympathetic dominance in 
the obese children, which was more significant in the insulin-
resistant subgroup. Large-scale prospective studies are 
needed to delineate the exact mechanisms that take part in the
interactions between obesity, insulin resistance and autonomic
functions. 
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